We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
732
Increased
2,941
Reduced
2,326
Closed
738

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
176
Kimberly-Clark
KMB
$37.3B
$4.25M 0.1%
31,470
-28,973
-48% -$3.82M
GD icon
177
General Dynamics
GD
$104B
$4.24M 0.1%
19,146
-12,949
-40% -$2.98M
EOG icon
178
EOG Resources
EOG
$71.5B
$4.21M 0.09%
38,126
-48,901
-56% -$6.07M
VRSK icon
179
Verisk Analytics
VRSK
$24.6B
$4.21M 0.09%
24,313
-31,996
-57% -$5.97M
TJX icon
180
TJX Companies
TJX
$177B
$4.17M 0.09%
74,624
-118,218
-61% -$7.16M
QID icon
181
ProShares UltraShort QQQ
QID
$251M
$4.11M 0.09%
31,411
-97,973
-76% -$11.2M
NOC icon
182
Northrop Grumman
NOC
$79.2B
$4.07M 0.09%
8,495
-11,120
-57% -$5.11M
SRE icon
183
Sempra
SRE
$55.3B
$4.05M 0.09%
53,960
-34,792
-39% -$2.79M
ARKG icon
184
ARK Genomic Revolution ETF
ARKG
$1.66B
$4.04M 0.09%
128,453
-97,862
-43% -$3.42M
AZN icon
185
AstraZeneca
AZN
$250B
$4.01M 0.09%
30,385
-18,669
-38% -$2.45M
CEG icon
186
Constellation Energy
CEG
$94.7B
$4.01M 0.09%
69,987
-27,743
-28% -$1.67M
ES icon
187
Eversource Energy
ES
$27.3B
$4.01M 0.09%
47,428
-8,852
-16% -$786K
GE icon
188
GE Aerospace
GE
$396B
$4M 0.09%
100,960
-192,008
-66% -$9.3M
BDX icon
189
Becton Dickinson
BDX
$47B
$3.99M 0.09%
16,194
-26,000
-62% -$6.6M
SCHW
190
Charles Schwab
SCHW
$188B
$3.98M 0.09%
62,971
-208,598
-77% -$14.4M
CLX icon
191
Clorox
CLX
$12.8B
$3.95M 0.09%
28,044
-12,936
-32% -$1.85M
VTI icon
192
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$3.95M 0.09%
20,919
+20,521
+5,156% +$4.22M
ED icon
193
Consolidated Edison
ED
$39.9B
$3.9M 0.09%
40,966
+5,275
+15% +$502K
ZTS icon
194
Zoetis
ZTS
$31.2B
$3.9M 0.09%
22,664
-48,563
-68% -$8.4M
JCI icon
195
Johnson Controls International
JCI
$93.1B
$3.81M 0.09%
79,510
-29,885
-27% -$1.66M
CI icon
196
Cigna
CI
$71.5B
$3.8M 0.09%
14,409
-30,531
-68% -$7.87M
DXCM icon
197
DexCom
DXCM
$31.2B
$3.75M 0.08%
50,258
-55,274
-52% -$5.04M
AJG icon
198
Arthur J. Gallagher & Co
AJG
$64.3B
$3.71M 0.08%
22,780
-6,050
-21% -$1M
ALGN icon
199
Align Technology
ALGN
$12.5B
$3.71M 0.08%
15,696
-13,066
-45% -$4.01M
SGEN
200
DELISTED
Seagen Inc. Common Stock
SGEN
$3.69M 0.08%
20,823
-15,606
-43% -$2.25M

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 738 positions and reducing 2,326 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 732 new positions and closed 738 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.